ClinConnect ClinConnect Logo
Search / Trial NCT06786975

Effectiveness and Acceptability of SDF Compared to ART for the Management of Early Childhood Caries

Launched by UNIVERSIDAD DE LA FRONTERA · Jan 15, 2025

Trial Information

Current as of July 24, 2025

Not yet recruiting

Keywords

Early Childhood Caries Silver Diamine Fluoride Atraumatic Restorative Treatment

ClinConnect Summary

This clinical trial is looking at two different treatments for young children with early childhood caries, which is a type of tooth decay. The researchers want to find out if Silver Diamine Fluoride (SDF), a liquid that helps stop cavities, is more accepted and effective than Atraumatic Restorative Treatment (ART), a method where cavities are filled without drilling. The study will include children aged 2 to 5 years who have at least one cavity that has not affected the nerve of the tooth. Parents will need to provide consent for their child’s participation.

If eligible, children will receive one of the two treatments, and their parents will be asked to fill out surveys about their child’s oral health before and after treatment. The study will involve follow-up visits at 6 and 12 months to see how well the treatments worked and how satisfied families are with the care provided. This trial is important because it aims to improve how we manage tooth decay in young children, making dental care more effective and acceptable for families in the community.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children belonging to INTEGRA or JUNJI kindergarten, from 2 years up to 5 years and 11 months with informed consent signed by parents and assent from the child.
  • Children with at least one active cavitated caries lesion, extended in dentin with no signs of pulp involvement and diagnosed with ICDAS code 5.
  • Exclusion Criteria:
  • Children with underlying systemic disease or disability
  • Children with known allergies to dental materials used
  • Children with transitory residence
  • Children with severe alterations of the dental estructure

About Universidad De La Frontera

Universidad de la Frontera is a distinguished academic institution dedicated to advancing health sciences through innovative research and clinical trials. Located in Chile, the university fosters a collaborative environment that integrates multidisciplinary expertise to address pressing health challenges. With a commitment to ethical standards and patient safety, Universidad de la Frontera actively engages in clinical research aimed at improving healthcare outcomes and contributing valuable insights to the global medical community. Its robust research infrastructure and emphasis on education position it as a leader in the field of clinical trials and translational medicine.

Locations

Temuco, , Chile

Temuco, La Araucanía, Chile

Patients applied

0 patients applied

Trial Officials

Patricia Muñoz, Master

Study Director

Universidad de La Frontera

Patricia Pineda, Master

Study Chair

Universidad de La Frontera

Carlos Zaror, Doctor

Study Chair

Universidad de La Frontera

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported